{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-290309","form_type":"8-K","ticker":"TCRX","cik":"0001783328","company_name":"TScan Therapeutics, Inc.","filed_at":"2023-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.411006+00:00","generated_at":"2026-06-07T16:20:17.620171+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"TScan Therapeutics appoints R. Keith Woods to Board of Directors, effective immediately","bullets":["Woods appointed as Class II director, serving on Audit and Compensation Committees.","Over 30 years life science experience; most recently COO of argenx, leading commercialization.","Received option to purchase 17,500 shares of TCRX common stock, vesting over one year or until 2024 annual meeting.","Board committees: Audit (Woods, Dorton, Gruia, Klencke); Compensation (Woods, Biggar, Dorton, Klencke)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-290309","json":"https://secwatch.observer/filing/0001193125-23-290309.json","markdown":"https://secwatch.observer/filing/0001193125-23-290309.md","text":"https://secwatch.observer/filing/0001193125-23-290309.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783328/000119312523290309/0001193125-23-290309-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783328/000119312523290309/d891696d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:20:17.620171+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cbc1ac0dbd","claim":"R. Keith Woods was appointed as Class II director at TScan Therapeutics, Inc..","evidence_excerpt":"On December 6, 2023, the Board of Directors (the “Board”) of TScan Therapeutics, Inc. (the “Company”) appointed R. Keith Woods, to the Board, effective December 6, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1783328/000119312523290309/0001193125-23-290309-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}